A microtiter assay for quantifying protein-protein interactions associated with cell-cell adhesion

Journal of Biomolecular Screening

Volumn 12, Issue 5, 2007, Pages 683-693

  Graham, Nicholas A ^a   Pope, Melissa D ^b   Rimchala, Tharathorn ^c   Huang, Beijing K ^a   Asthagiri, Anand R ^a,d  

^a California Institute of Technology   (United States)

^b California Institute of Technology   (United States)

^c Massachusetts Institute of Technology   (United States)

^d NONE   (United States)

Author keywords

catenin; Cancer; Cell cell adhesion; E cadherin; ELISA

Indexed keywords

BETA CATENIN; UVOMORULIN;

ARTICLE; CANCER; CARCINOGENESIS; CELL ADHESION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MICROTITER PLATE ASSAY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS;

ANIMALS; ANTIBODIES, MONOCLONAL; BETA CATENIN; BIOLOGICAL ASSAY; BREAST NEOPLASMS; CADHERINS; CELL ADHESION; CELL LINE; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FEMALE; HUMANS; KIDNEY; MICE; PLASMIDS; PROTEINS; REPRODUCIBILITY OF RESULTS; RETROVIRIDAE; TRANSFECTION;

EID: 34547749386     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057107301941     Document Type: Article

References (30)

1. Wijnhoven BP, Dinjens WN, Pignatelli M.: E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg 2000 ; 87: 992-1005.
2. Christofori G., Semb H.: The role of cell-adhesion molecule E-cadherin as a tumour suppressor gene. Trends Biochem Sci 1999 ; 24: 73-76.
3. Angst BD, Marcozzi C., Magee AI: The cadherin superfamily. J Cell Sci 2001 ; 114: 625-626.
4. Hirohashi S.: Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 1998 ; 153: 333-339.
5. De Leeuw WJ, Berx G., Vos CB, Peterse JL, Van de Vijver MJ, Litvinov S.,, et al. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 1997 ; 183: 404-411.
6. Ohene-Abuakwa Y., Noda M., Perenyi M., Kobayashi N., Kashima K., Hattori T.,, et al. Expression of the E-cadherin/catenin (α-, β-, and γ-) complex correlates with the macroscopic appearance of early gastric cancer. J Pathol 2000 ; 192: 433-439.
7. Behrens J., Vakaet L., Friis R., Winterhager E., Van Roy F., Mareel MM,, et al. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/β-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol 1993 ; 120: 757-766.
8. Fujita Y., Krause G., Scheffner M., Zechner D., Leddy HE, Behrens J.,, et al. Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol 2002 ; 4: 222-231.
9. Lu Z., Ghosh S., Wang Z., Hunter T.: Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of βcatenin, and enhanced tumor cell invasion. Cancer Cell 2003 ; 4: 499-515.
10. Avizienyte E., Wyke AW, Jones RJ, McLean GW, Westhoff MA, Brunton VG,, et al. Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling. Nat Cell Biol 2002 ; 4: 632-638.
11. Gottardi CJ, Gumbiner BM: Distinct molecular forms of β-catenin are targeted to adhesive or transcriptional complexes. J Cell Biol 2004 ; 167: 339-349.
12. Roura S., Miravet S., Piedra J., Garcia de Herreros A., Dunach M.: Regulation of E-cadherin/catenin association by tyrosine phosphorylation. J Biol Chem 1999 ; 274: 36734-36740.
13. Catimel B., Layton M., Church N., Ross J., Condron M., Faux M.,, et al. In situ phosphorylation of immobilized receptors on biosensor surfaces: application to E-cadherin/β-catenin interactions. Anal Biochem 2006 ; 357: 277-288.
14. Kim VN, Mitrophanous K., Kingsman SM, Kingsman AJ: Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. J Virol 1998 ; 72: 811-816.
15. Zhang JH, Chung TD, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999 ; 4: 67-73.
16. Wang J., Qiang H., Zhang C., Liu X., Chen D., Wang S.: Detection of IgGbound lipoprotein(a) immune complexes in patients with coronary heart disease. Clin Chim Acta 2003 ; 327: 115-122.
17. Strandberg K., Kjellberg M., Knebel R., Lilja H., Stenflo J.: A sensitive immunochemical assay for measuring the concentration of the activated protein C-protein C inhibitor complex in plasma: use of a catcher antibody specific for the complexed/cleaved form of the inhibitor. Thromb Haemost 2001 ; 86: 604-610.
18. Ogasawara K., Mashiba S., Wada Y., Sahara M., Uchida K., Aizawa T.,, et al. A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery disease. Atherosclerosis 2004 ; 174: 349-356.
19. Harris TJ, Peifer M.: Decisions, decisions: β-catenin chooses between adhesion and transcription. Trends Cell Biol 2005 ; 15: 234-237.
20. Butler JE, Navarro P., Sun J.: Adsorption-induced antigenic changes and their significance in ELISA and immunological disorders. Immunol Invest 1997 ; 26: 39-54.
21. Tait L., Soule HD, Russo J.: Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10. Cancer Res 1990 ; 50: 6087-6094.
22. Munemitsu S., Albert I., Souza B., Rubinfeld B., Polakis P.: Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci USA 1995 ; 92: 3046-3050.
23. Korinek V., Barker N., Morin PJ, van Wichen D., de Weger R., Kinzler KW,, et al. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997 ; 275: 1784-1787.
24. Owens DW, McLean GW, Wyke AW, Paraskeva C., Parkinson EK, Frame MC,, et al. The catalytic activity of the Src family kinases is required to disrupt cadherin-dependent cell-cell contacts. Mol Biol Cell 2000 ; 11: 51-64.
25. Piwnica-Worms H., Saunders KB, Roberts TM, Smith AE, Cheng SH: Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src. Cell 1987 ; 49: 75-82.
26. Cartwright CA, Eckhart W., Simon S., Kaplan PL: Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain. Cell 1987 ; 49: 83-91.
27. Galliher AJ, Schiemann WP: β3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells. Breast Cancer Res 2006 ; 8: R42.
28. Hulsken J., Birchmeier W., Behrens J.: E-cadherin and APC compete for the interaction with β-catenin and the cytoskeleton. J Cell Biol 1994 ; 127: 2061-2069.
29. Ress A., Moelling K.: Bcr interferes with β-catenin-Tcf1 interaction. FEBS Lett 2006 ; 580: 1227-1230.
30. Haraguchi K., Nishida A., Ishidate T., Akiyama T.: Activation of β-catenin-TCF-mediated transcription by non-receptor tyrosine kinase v-Src. Biochem Biophys Res Commun 2004 ; 313: 841-844.